ba0001pp442 | Osteoporosis: treatment | ECTS2013
Maurille Feudjo Tepie
, Moller Gerd
, Hadji Peyman
, Ferreira Irene
, Siddhanti Suresh
, Boonen Stephen
, Fahrleitner-Pammer Astrid
, Papaioannou Nikos
Treatment of postmenopausal osteoporosis (PMO) has been traditionally hampered by poor persistence and adherence to short-term (≤1-monthly) medications. The efficacy of 6-monthly (Q6M) denosumab treatment has been proven in clinical trials, but effectiveness will be dependent on persistence and adherence in routine clinical practice. This study is designed to evaluate real-world persistence and adherence to denosumab, and to establish how this is best assessed in long-ac...